2017 First and Gold Gala
Tuesday, October 18, 2016
When: Friday, August 11, 2017
Time: 7 p.m. – 11 p.m.
Contact: Lauren Korthoff at firstname.lastname@example.org or 404-596-5507 to secure your place at the First and Gold Gala.
Group Rate Hotel Accommodations at the Embassy Suites: CLICK HERE
To register, view, and bid on current Silent and Live Auction items: CLICK HERE
About this Charity Event
Please join Curing Kids Cancer as we celebrate our second annual First and Gold Gala on Friday, August 11, 2017 at The College Football Hall of Fame. Curing Kids Cancer focuses on funding some of the world's most innovative and cutting-edge treatments for childhood cancers.
Lee Corso, legendary analyst of ESPN’s College GameDay will be honored at this year's gala. Coach Corso will be recognized for his decade of service to Curing Kids Cancer; he has been the chairman of Curing Kids Cancer’s executive advisory board and chairman of Coaches Curing Kids Cancer by being a steadfast supporter of our mission to find cures for childhood cancers.
“Since he became the honorary Chairman of Curing Kids Cancer, Lee has devoted his time and talent to help us further our mission, which is to fund innovative research and treatments to find cures for all childhood cancers in our lifetime,” said Curing Kids Cancer founder and president Grainne Owen.
The evening features interactive all-access passes to the College Football Hall of Fame, a cocktail reception, silent & live auctions, a 3-course dinner and music from our featured DJ. This paramount black-tie suggested event is surely not to be missed!
Most notably, your patronage at the First and Gold Gala will support the mission of Curing Kids Cancer — to turn all childhood cancers from life-threatening diseases into curable ones in our lifetime. Some recent recipients of Curing Kids Cancer’s support have included:
- The Dana Farber Cancer Institute received another $55,000 from Curing Kids Cancer in 2016 to fund Kimberly Stegmaier, M.D.’s work with epigenetics, which is the study of how genes are affected by external and environmental factors. Dr. Stegmaier’s laboratory focuses on two common pediatric tumors: Ewing sarcoma and neuroblastoma. Last year, Dr. Stegmaier was a recipient of a $200,000 grant. The funds this year will help to progress her research.
- Another $150,000 was given by Curing Kids Cancer in 2016 to research being done by Meenashki Hegde, M.D. at Texas Children’s Cancer Center. Dr. Hegde focuses engineering Chimeric Antigen Receptor (CAR) T cell therapy to be used for anti-glioma (brain) therapy. This enables the body’s own T Cells to be genetically re-engineered to kill specific cancer cells with minimal side effects.
- The Hospital for Sick Children in Toronto was awarded a $150,000 grant by Curing Kids Cancer in 2016 to fund the groundbreaking work of Cynthia Hawkins, M.D.'s research on high-grade gliomas, also known as brain tumors. Dr. Hawkins goal is to create a novel high-grade glioma specific targeted drug delivery system to prolong, localize and protect drug interactions within tumor tissues.
Please contact Lauren Korthoff at 404-596-5507 or email@example.com for questions.